Randomized Comparison of Vascular Healing of a Polymer-Free Biolimus-eluting BIOFREEDOM Stent With a Biodegradable-Polymer Sirolimus-eluting ORSIRO Stent in Patients With ST-segment Elevation Myocardial Infarction
Latest Information Update: 07 Sep 2023
Price :
$35 *
At a glance
- Drugs Umirolimus (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- Acronyms OCT STEMI SOIX
- 17 Sep 2020 Planned End Date changed from 1 Sep 2022 to 1 Sep 2023.
- 17 Sep 2020 Status changed from recruiting to active, no longer recruiting.
- 31 Oct 2018 New trial record